chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started having excema; Having bad itchiness on my vaginal area/dealt with this for over a year/still an ongoing itch around vagina, and vigina; Still an ongoing itch under arms/still an ongoing itch under breasts/still an ongoing itch on stomach/still an ongoing itch on legs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ECZEMA (Started having excema), VULVOVAGINAL PRURITUS (Having bad itchiness on my vaginal area/dealt with this for over a year/still an ongoing itch around vagina, and vigina) and PRURITUS (Still an ongoing itch under arms/still an ongoing itch under breasts/still an ongoing itch on stomach/still an ongoing itch on legs) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced ECZEMA (Started having excema), VULVOVAGINAL PRURITUS (Having bad itchiness on my vaginal area/dealt with this for over a year/still an ongoing itch around vagina, and vigina) and PRURITUS (Still an ongoing itch under arms/still an ongoing itch under breasts/still an ongoing itch on stomach/still an ongoing itch on legs). The patient was treated with CLOTRIMAZOLE at an unspecified dose and frequency and BETAMETHASONE at an unspecified dose and frequency. At the time of the report, ECZEMA (Started having excema), VULVOVAGINAL PRURITUS (Having bad itchiness on my vaginal area/dealt with this for over a year/still an ongoing itch around vagina, and vigina) and PRURITUS (Still an ongoing itch under arms/still an ongoing itch under breasts/still an ongoing itch on stomach/still an ongoing itch on legs) had not resolved.            No concomitant medications were reported.  The patient reported that patient had never got COVID. patient was fully vaccinated with all 3 moderna vaccines. Patient have never been allergic to any medications. However, after 2nd vaccine, patient started having excema. Especially having bad itchiness on patient's vaginal area. Patient dealt with this for over a year. Patient saw an OBGYN. She medicated Clotrimazole and betamethasone and that helped. The best. It still didn't stop it all together. Patient was daily using it. And when don't have any refills patient used betamethasone depropionate itself. It helped a little better than any other. It was still an ongoing itch. Under arms, under breast, stomach, legs around vagina, and vigina. Patient have been feeling with this all from the 2nd vaccine afterwards.
eyelids are all puffy, red and sore; eyelids are all puffy, red and sore; eyelids are all puffy, red and sore; This is a spontaneous report received from a non-contactable consumer, the patient. This female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 12Mar2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On the morning of 15Mar2021, the patient experienced her eyelids are all puffy, red and sore. The clinical outcome of the "eyelids are all puffy, red and sore" was unknown.   The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow-up.
Cough, wheezing, arm pain on left (where shot was given) into finger tips, chest tightness. Started about 1.5 hours after vaccine given, mostly resolved by the next day except arm pain which lasted into lower arm x 1 week and upper arm x about 1 month.
Patient presented with lump on arm, on or near injection site. No discoloration noted, but warm to touch. Patient complaining of some pain, but not too bad.
38,9 centigrade fever, lots of shaking, headache, very very tired and ache with slight pain on right arm
Right SQ vaccine injection, swelling, warm to touch, area measured 50 x 30 cm on right arm. Pt had been given MMR vaccine.
Arm swelled up to my elbow; red; hot; Initial information was received on 22-Nov-2021 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional (patient) via social media.  This case involves an unknown age and gender patient who experienced arm swelled up to my elbow (peripheral swelling), red (erythema) and hot (skin warm) while receiving INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.   Past medical treatment(s), vaccination(s) concomitant medication and family history were not provided.   On an unknown date (Wednesday), the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious arm swelled up to my elbow (peripheral swelling), red (erythema) and hot (skin warm) (unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was unknown for all events.  There will be no information available on the batch number for this case.
migraine; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 26Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter wanted to know if the patient could take Sudafed PE for a migraine that she was experiencing from an unspecified date. The patient received the first dose of the vaccine yesterday afternoon (26Jan2021), in which her doctor recommended her to not take ibuprofen within the first 24 hours of the vaccine. The outcome of event was unknown.  Information about lot/batch number has been requested.
it was rpt fr RN concerning pt who was vax &  on 7dec98 lab eval revealed a lack of response
A couple hours after shot, got red in face, flushed, hot feeling, shortness of breath and face and hands puffy. 1-2 days later reported to my work. Lasted 2-3 days. 2 wks later got pancreatitis lasted 2 months. Then got pleurisy (chronic) that turned into costochondritis 12/2010-4/2011 (referred to a rheumatologist).
28 yo M with history of liver transplant was vaccinated with Pneumovax 23 IM in right deltoid on 4/8/22 at 0850 the end of his clinic visit.  Lot # U023826 (NDC 0006-4943-01).   When the patient was at the checkout desk and awaiting labs, he was experiencing shortness of breath and feeling like throat was closing.  Reportedly cyanotic.  RRT called.  Found patient sitting in lobby awake, alert, and flushed.  Pt reported  sensation as though his throat was closing.  VS at 0857- BP 147/103, HR 92, respirations 26, pO2 91% on RA. Patient was placed on 4L O2. Patients stated his head felt like it was on fire, chest and back was hurting. Per reporter, epinephrine was ordered but not given. Patient symptoms started to resolve. VS at 0911- BP 151/100, HR 68, respirations 22, POX 96% on 4l O2. O2 removed and POX remained stable 94-96% on RA. Patient declined to go to emergency room. AMA forms signed with emergency staff.  No SOB at 0923 or 0928.  Allergy added to patient's profile by Medical staff.
the employee signed paperwork to receive 1st dose vaccine She was given Moderna but she wanted Pfizer Patient did NOT verbally state what brand she wanted when she came to clinic she crossed out an area on the bottom of the consent that was for office use only and changed to Pfizer which we did not catch it was in an area that was hard to read and should not have been used by the patient to state what manufacturer she wanted
This case was reported by a consumer via call center representative and described the occurrence of pain in a 70-year-old female patient who received SHINGRIX. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain, shivering and fatigue. On an unknown date, the outcome of the pain, shivering and fatigue were recovered/resolved. The reporter considered the pain, shivering and fatigue to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient's friend. The age at vaccination was not reported, however it could be 69 or 70 years. The reporter stated that the patient experienced some side effects such as pain, shivering and fatigue for a week after receiving the SHINGRIX vaccine. The patient had denied permission to contact their physician. The reporter did not know any other information about the patient or the patient's healthcare provider.
Starting the day after his flu shot on 1/19/05, he started getting a mysterious outbreak of pinpoint sized red hives up his arms on the inside (especially the left one where he received the flu shot), and around the neck area.  He stated is started Thursday AM, 1/20/05, with a sore arm that started feeling 'tingly', mainly in his left arm and traveling up his neck and going to his right arm as well.  He stated the hives come and go, and have lasted until today, 1/27/05.  Last night on 1/26/05, he stated his left arm and upper chest and neck began to itch, and a cluster of what looked like small, flat mosquito bite-like hives appeared up his left arm.  They lasted for approximately 2 hours and went away; he did not take any OTC or prescription meds to treat the hives.  He stated his hives last from approximately 1/2 day to all day long.
Information has been received from a mother concerning her 16 month old daughter with no known allergies who on 12/11/03 (previously reported as 12/19/03) was vaccinated IM into the right upper thigh with a first dose of MMRII (Lot # 646121/0611N).  On the seventh day, on approximately 12/26/03, the pt developed a few vesicles and then over the week some more were noted. A brief rhinorrhea was reported as well. The mother reported that the child may have had "atypical measles" and she was unsure of what she was seeing. A facial rash was also noted and reported as "almost like roseola". The pt had no fever or wheezing, was playful but minimally "clinging". The mother reported that the child would be assessed at the clinic. In follow up information from a physician, it was noted that the pt developed a rash on 12/20/03. The pt was seen for an office visit and was diagnosed with right otitis media, acute upper respiratory infection, rhinorrhea and viral exanthem. The physician reported that at the time of vaccination, the pt had serious otitis media, purulent rhinitis and was under treatment with Pediazole. Concomitant vaccinations on 12/11/03 included a dose of Trihibit (Lot # SU1257AB), a dose of Fluzone (Lot # U1287AA) and tuberculin purified protein derivative, reported as "PPD" (Lot # C12628A). The physician reported that the pt did not have adverse events following prior vaccinations.  It was reported that the pt recovered on either 01/06/04 or 01/10/04.  Additional information is not expected.
45 mins p/receiving flu vax started feeling heaviness in chest, then started vomiting then heart rate got fast then slowed down-exp chest tightness & SOB; next Am HR 130, felt better went to work, vomited again HR elevated 140-169;
Soreness for 6 days.., day 6 redness and  increases pain in bend of arm.. which progressed  to pitting edema, redness, swelling, severe pain going up and down arm. Went to doctor office 9/1/21, suspected as cellulitis starting in elbow, treated as such with antibiotic and anti inflammatory, clindamycin and mobic.
Case number PHEH2014US024306 is an initial spontaneous report from a nurse received on 02 Dec 2014 and a follow up report from the nurse received on 19 Jan 2015. This report refers to a 43 years old male patient. Historical conditions were not reported. Vaccination history included flu vaccine (manufacturer and batch number: not reported) and it was well tolerated. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 14511P, expiry date: Mar 2015) intramuscularly in the right deltoid at a dose of 0.5 ml on 05 Nov 2014. The nurse reported that FLUVIRIN was stored at 49 F for one hour and 15 minutes before administration to the patient. The nurse reported that before vaccination the prefilled syringe (PFS) of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. No adverse event was reported following this maladministration (incorrect storage of drug). No further information was provided. Follow up report from the nurse received on 19 Jan 2015: Vaccination history and site of FLUVIRIN vaccination were updated.
Headache, Myalgia, Angioedema, SkinRash, Rash, UrticariaPruritus, NauseaVomiting, ARM BECAME PROGRESSIVELY MORE PAINFUL; THROB, LEFT WORK ONE HOUR EARLY, FELT TIRED; MYALGIA LEFT ARM, NAUSEA Narrative:  FIRST FEW HOURS LEFT ARM PAIN AND THROBBING, HEADACHE ABOUT AN HOUR AFTER VACCINE; NAUSEA IN THE AFTERNOON, LEFT WORK ONE HOUR EARLY, AT HOME, LAID DOWN, WHEN AWOKE, ABOUT 9P, FACE WAS ITCHING, SWELLING OF FACE AND EYES 9CARRIES EPI PEN, SUFFERS FROM ALLERGIES), USED DESONIX CREAM ON FACE (FOR ITCHING FROM MD FOR ALLERGIC REACTIONS), LIPS TINGLING, TOOK BENADRYL PO, TUESDAY AM RED SPLOTCHES ON FACE, USED DESONIX AND TOOK BENADRYL. TODAY (WED) STILL ITCHING AROUND CHEEKS, UNDER EYES, AROUND MOUTH. ON MONDAY THROUGH TODAY FELT TIRED AND HEADACHE. (NOT RESOLVED; ONGOING); PLANS TO TAKE BENADRYL WHEN ARRIVES HOME TODAY.
Injection site itched; red spots on his back; itchy rash on his back; This is a spontaneous report from a contactable consumer or other non hcp. A male patient of an unspecified age received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6202) via an unspecified route of administration on 28Feb2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced itchy rash on his back on 04Mar2021, injection site itched on an unspecified date, red spots on his back on an unspecified date. Therapeutic measures were taken as a result of itchy rash on his back, injection site itched, red spots on his back was Caladryl. The outcome of the events rash pruritic, vaccination site pruritus, rash macular was unknown.  No follow-up attempts are possible. No further information is expected.
Rash on abdomen and chest - no drainage or bleeding, no pruritus or pain No other associated signs and symptoms
Client Received FLUZONE 0.5ml for ages 3 and up. Client was only 2 years and 10 months old.  Client should have received FLUZONE 0.25ml for age 6 to 35 months. No reaction noted.
SITE OF VACCINE- SWOLLEN, HIVES FROM FRONT OF THIGH DOWN AROUND KNEE. RAISED, EXTREMELY RED AND ITCHY.
Right arm at site of DTaP is red, swollen (3 inches) warm to touch, no streaking.
A non-serious spontaneous report of facial numbness, extreme dizziness and lip tingling has been received from a non-health professional concerning a 27-year-old female, subsequent to FLUMIST. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient received FLUMIST on 13-Oct-2010 for an unknown indication. One and one-half hours after receiving FLUMIST, the patient experienced facial numbness, extreme dizziness and lip tingling. The outcome for the reported adverse events was not reported.
Chest and throat irritation, breathing difficulty. Also eye irritation and swelling. Headache.
Patient presented with severe chest pain 6/24, admitted to r/o MI.  7/2/10 developed classic shingles rash in a ~T5 distribution.
Two days post vax, the pt developed a fever and 15 minute episode of seizure activity.
Medium sized hive like lump that has changed from Ted and warm to a lump to now being a darker inner circle surrounded by red rash like outer circle (this morning 1/25/21). Although we don?t think it?s related I will mention I experienced tightened upper back muscles to the point that I couldn?t sit up from my bed the Wednesday morning after receiving the vaccine. Similar tightness (could barely turn my head as well the following day as well). Some stiffness is still present today.
Patient called 4 hours post vaccine to inquired about the soreness of her arm. Told her that up to 7% can have grade 3 pain and it can be painful at rest and limit daily activities. Advised her to use comfort measures and tylenol for pain relief and if she needed to seek additional help to go to the ER/Urgent care. Patient then stated that she started to feel lightheaded and nauseous and was going to try to eat something. She was very off balance. She then went to sit down only to find herself passed out on the floor. She called a neighbor who brought her to the ER. She was clammy, nauseous, and felt like diarrhea  and having trouble breathing. She told them she was having an allergic reaction and they took her back. She was at the ER for 1 hour before given steroids which helped immediately per patient. I follow up with the patient the next day 01/26 and she was still having significant arm pain. I informed her that could last for a few more days (possibly up to 1 week). Told her to follow up with MD and I will call her to submit the AE.
About 5 minutes after getting the vaccine, I started having heart palpitations. They took my blood pressure and it was elevated, so they sent me to the ER. There was a 9 hour wait, so I decided to leave, but I did have an EKG while there. I have continued to have heart palpitations even though my EKG was normal. I will follow up with my primary doctor as soon as I can.
Patient had a reaction at the site of the PCV-13, approximately 36-48 hours following vaccination.  She had a 7 cm area of redness and induration, but no significant pain.  She also has had a 102 fever on and off. Dx'd with cellulitis.  We will continue with cool compress and she can have ibuprofen.
3 CM AREA OF ERYTHEMA AROUND INJECTION SITE, WITH MULTI VESICLES DISTAL TO SITE, PROB SELF INCULATION. BODY ACHES, CHILLS, FATIGUE.
Patient received 2nd dose Pfizer COVID vaccine to left arm. 10 minutes after receiving vaccine patient complained of feeling nauseated and dizzy. Patient's blood pressure at 1310 sitting 122/74, pulse 60.  Dr notified. Patient assisted to exam table and supine position with pillow under bilat knees at 1310. Blood pressure at this time 124/80. Cold wet paper towel placed on patient's forehead. Attempted to sit up at 1320 and patient stated dizziness returned. Patient mentioned at this time he has a history of vertigo. Patient assisted to supine position again. Blood pressure 120/70.  At 1325 patient assisted to sitting position and blood pressure 120/78. Patient stated he was feeling better. Patient assisted to restroom. After using facilities, patient felt much better and was discharged to home.
On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ORAL PAIN (Mouth sores or blisters in mouth day after 1st dose). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, ORAL PAIN (Mouth sores or blisters in mouth day after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Had severe reaction; chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had severe reaction) and CHILLS (chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Had severe reaction) and CHILLS (chills). At the time of the report, VACCINATION COMPLICATION (Had severe reaction) outcome was unknown and CHILLS (chills) had resolved. Not Provided          No concomitant medication information was provided. The patient  stated when she went to the doctor's office, the PA gave her a B12 shot and she thinks it might have been a reaction to receiving the B12 shot. The patient reported chills lasting until she got into a bathtub with hot water. No additional treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Event added-chills.
Acute onset of pain and limitation of range of motion in left arm and shoulder. Started 4 hours after administration of vaccine. No injection site erythema or induration. Pain worsening overnight. During clinical exam on following day, significant loss of glenohumeral range of motion (both active and passive) without erythema or swelling.
c/o screaming, fussy since vax 30JUL96;pt alert, drinks well, consolable but irritable;
started having hives all over his body; fever; chills; sore throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 20 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Oct2021 (Lot number: 30155BA) at the age of 20 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Pfizer COVID First dose:  10Sep2021, LOT: FD08CG, states she doesn't understand the writing, because the letters are all together, Expiry Date: Unknown, Unknown, Injection, left arm, unknown dosage, injection), administration date: 10Sep2021, when the patient was 20 years old, for COVID-19 Immunization. The following information was reported: URTICARIA (non-serious) with onset 04Oct2021, outcome "unknown", described as "started having hives all over his body"; PYREXIA (non-serious) with onset 02Oct2021, outcome "recovered" (02Oct2021), described as "fever"; CHILLS (non-serious) with onset 02Oct2021, outcome "recovered" (02Oct2021), described as "chills"; OROPHARYNGEAL PAIN (non-serious) with onset 02Oct2021, outcome "recovered", described as "sore throat".  Additional information: The patient was taking Pfizer COVID 19 Vaccine, they all decided because they had a 7 year old at home and he works so hopefully it helps. It was reported that she gave her age but its to report a side effect of the second dose of the Pfizer BioNTech COVID vaccine, for her son. He got the, well they all got the second dose of the vaccine on Friday, but he got fever, chills, sore throat and then by monday, he started having hives all over his body. Fever; chills; sore throat: Confirms began about 6 hours after getting the shot. He got it about 5:30 in the afternoon and started feeling that way over night, so confirms began 02Oct2021 and was just a one day thing and confirms recovered completely 02Oct2021. She confirmed the product the patient received was the Pfizer COVID 19 Vaccine.  No follow-up attempts are possible. No further information is expected.